# A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

> **NCT05827016** · PHASE3 · RECRUITING · sponsor: **Bristol-Myers Squibb** · enrollment: 1216 (estimated)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Iberdomide
- **DRUG:** Lenalidomide

## Key facts

- **NCT ID:** NCT05827016
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-06-22
- **Primary completion:** 2029-03-15
- **Final completion:** 2036-01-01
- **Target enrollment:** 1216 (ESTIMATED)
- **Last updated:** 2026-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05827016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05827016, "A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT05827016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*